Impact of a direct-to-consumer information campaign on prescription patterns for overactive bladder.

ABSTRACT:

Background

Direct-to-consumer information (DTCI) campaign is a new medium to inform and empower patients in their decision-making without directly promoting specific drugs. However, little is known about the impact of DTCI campaigns, expanding rapidly in developed countries, on changes in prescription patterns. We sought to determine whether a DTCI campaign on overactive bladder increases the prescription rate for overactive bladder treatment drugs.

Methods

We performed a 3-year retrospective cohort study of 1332 participants who were diagnosed overactive bladder but not prescribed treatment drugs prior to the examined DTCI campaign (exposure), using the health insurance claims dataset of the Japan Medical Data Center (November 19, 2010 to November 18, 2013). The DTCI campai

SUBMITTER: Zaitsu M 

PROVIDER: S-EPMC5934904 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature